CABG surgery ‘safe’ 2-3 days after stopping ticagrelor
A shorter suspension of antiplatelet therapy was also linked to shorter hospital stay, researchers report
Heart surgery for patients with acute coronary syndrome just two to three days after ceasing ticagrelor therapy causes no more severe bleeds than a longer wait, a landmark trial shows.
The RAPID CABG trial is the first randomised controlled study comparing early coronary artery bypass graft (CABG) surgery with surgery at five to seven days after stopping the blood thinner, which is the recommended delay in many guidelines, including Australia’s.
